INGN

Inogen Inc
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$160.03M
P/E Ratio
—
EPS
$-1.21
Beta
1.49
52W High
$7.67
52W Low
$5.04
50-Day MA
$5.95
200-Day MA
$6.24
Dividend Yield
—
Profit Margin
-6.94%
Forward P/E
—
PEG Ratio
3.48

About Inogen Inc

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other physicians, and third-party payers in the United States and internationally. The company is headquartered in Goleta, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$354.30M
Gross Profit (TTM)$157.69M
EBITDA$-8.09M
Operating Margin-5.13%
Return on Equity-13.10%
Return on Assets-5.84%
Revenue/Share (TTM)$13.05
Book Value$7.06
Price-to-Book1.01
Price-to-Sales (TTM)0.45
EV/Revenue0.248
EV/EBITDA-17.60
Quarterly Earnings Growth (YoY)87.30%
Quarterly Revenue Growth (YoY)3.00%
Shares Outstanding$26.54M
Float$23.13M
% Insiders12.95%
% Institutions79.30%

Historical Volatility

HV 10-Day
74.23%
HV 20-Day
64.59%
HV 30-Day
66.36%
HV 60-Day
50.18%
HV Rank
100.0%

Volatility is currently expanding

Analyst Ratings

Consensus ($12.00 target)
1
Strong Buy
1
Buy

Latest News

Inogen, Inc. (INGN) Q3 2026 Earnings Call Transcript

Inogen, Inc. ( INGN ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Lorna Williams - Senior Vice President of Investor Relations Andrew Reding - President, CEO & Director Jason Richardson - CFO, Executive VP & Treasurer Presentation Operator Welcome to Inogen's Third Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, November -- as a reminder, this conference is being recorded today, November 5, 2026.

Seeking Alpha11/6/2026Neutral
Inogen Q2 Earnings Call Highlights

Inogen NASDAQ: INGN reported second-quarter 2026 revenue of $95.1 million, up 3% from a year earlier, as international growth, portable oxygen concentrator demand and contributions from newer products offset continued pressure in its U.S. direct-to-consumer business.

MarketBeat8/7/2026Negative

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on INGN and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026